SOFA-2 Score in Turkish ICUs

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIzmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

About this trial

This study aims to evaluate how well a new scoring system called the Sequential Organ Failure Assessment-2 (SOFA-2) works in adult intensive care units in Türkiye.

SOFA-2 is designed to measure the severity of organ dysfunction in critically ill patients using routinely collected clinical and laboratory data. It is an updated version of the original SOFA score and reflects modern intensive care practices.

In this multicenter observational study, adult patients admitted to participating intensive care units will be followed during their ICU stay. SOFA and SOFA-2 scores will be calculated during the first 24 hours of admission, and in patients with longer stays, additional scores will be recorded. No additional tests or treatments will be performed as part of the study.

The main goal of the study is to examine the relationship between SOFA-2 scores and intensive care unit mortality. The results are expected to help clinicians better assess disease severity and outcomes in critically ill patients.

Eligibility criteria

Qualifiers

Adults aged 18 years or older

Admission to a participating intensive care unit in Türkiye

Intensive care unit stay longer than 24 hours

Disqualifiers

Patients younger than 18 years

Pregnant patients

Organ donors

Patients with unknown intensive care unit discharge outcomes

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

5,200 Participants
are grouped into 1 trial group